Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: The HDDRISC study

International Journal of Cardiology

Volumn 97, Issue 3, 2004, Pages 543-550

  Godsland, Ian F ^a   Bruce, Raymond ^a   Jeffs, James A R ^a   Leyva, Francisco ^a   Walton, Christopher ^a   Stevenson, John C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cholesterol; Coronary heart disease; Factor analysis; Inflammation; Metabolic syndrome

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM GLOBULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FACTORIAL ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEALTH PROGRAM; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CORONARY DISEASE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; METABOLIC SYNDROME X; SOCIAL CLASS;

EID: 9244229008     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.05.008     Document Type: Article

References (46)

1. J. Danesh, R. Collins, P. Appleby, and R. Peto Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease JAMA 279 1998 1477 1482
2. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, and P. Appleby Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis Br. Med. J. 321 2000 199 204
3. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N. Engl. J. Med. 347 2002 1557 1565
4. R.G. Nelson, M.L. Sievers, W.C. Knowler, B.A. Swinburn, D.J. Pettitt, and M.F. Saad Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes Circulation 81 1990 987 995
5. J.B. Ruige, W.J.J. Assendelft, J.M. Dekker, P.J. Kostense, R.J. Heine, and L.M. Bouter Insulin and risk of cardiovascular disease: a meta-analysis Circulation 97 1998 996 1001
6. P. Lempiäinen, L. Mykkänen, K. Pyörälä, M. Laakso, and J. Kuusisto Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men Circulation 100 1999 123 128
7. R.L. Hanson, G. Imperatore, P.H. Bennett, and W.C. Knowler Components of the "metabolic syndrome" and incidence of type 2 diabetes Diabetes 51 2002 3120 3127
8. J.G. Canto, and A.E. Iskandrian Major risk factors for cardiovascular disease. Debunking the "Only 50%" myth JAMA 290 2003 947 949
9. G. Reaven Metabolic syndrome. Pathophysiology and implications for management of cardiovascular disease Circulation 106 2002 286 288
10. NCEP Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
11. K.G.M. Alberti, P.Z. Zimmet for the WHO Consultation Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus. Provisional Report of a WHO Consultation Diabet. Med. 15 1998 539 553
12. H.-M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, and J. Tuomilehto The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
13. A. Onat, K. Ceyhan, O. Basar, B. Erer, S. Toprak, and V. Sansoy Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation Atherosclerosis 165 2002 285 292
14. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women Circulation 107 2003 391 397
15. E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, and R.C. Bonadonna Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study Diabetes Care 26 2003 1251 1257
16. N. Sattar, A. Gaw, O. Scherbakova, I. Ford, D.S. O'Reilly, and S.M. Haffner Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419
17. J.B. Meigs Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? Factor analysis reveals patterns in the fabric of correlated risk factors Am. J. Epidemiol. 152 2000 908 911
18. M. Pyörälä, H. Miettinen, P. Halonen, M. Laakso, and K. Pyorälä Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men-the 22-year follow-up of the Helsinki Policemen Study Arterioscler. Thromb. Vasc. Biol. 20 2000 538 544
19. S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes Diabetologia 43 2000 148 155
20. J. Kuusisto, P. Lempiäinen, L. Mykkänen, and M. Laakso Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men Diabetes Care 24 2001 1629 1633
21. I.F. Godsland, F. Leyva, M. Worthington, C. Walton, and J.C. Stevenson Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the HDDRISC Study (HDDRISC-1) J. Intern. Med. 244 1998 33 41
22. F. Leyva, I.F. Godsland, C. Walton, M. Worthington, and J.C. Stevenson Factors of the metabolic syndrome-baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1) Arterioscler. Throm. Vasc. Biol. 18 1998 208 214
23. P. Ducimetiere, J.M. Warnet, and J.L. Richard Raised serum alpha-2 globulins as an independent risk factor of coronary heart disease J. Chronic Dis. 29 1976 423 429
24. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing Diabetes Care 22 1999 1462 1470
25. D.G. Cramp New automated method for measuring glucose by glucose oxidase J. Clin. Pathol. 20 1967 910 912
26. P. Trinder Determination of blood glucose using an oxidase-peroxidase system with non-carcinogenic chromogen J. Clin. Pathol. 22 1969 158 161
27. J.D.M. Albano, R.P. Ekins, G. Maritz, and R.C. Turner A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties Acta Endocrinol. 70 1972 487 509
28. G. Robertson, and D.G. Cramp An evaluation of cholesterol determinations in serum and serum lipoprotein fractions by a semi-automated fluorimetric method J. Clin. Pathol. 23 1970 243 245
29. D.G. Cramp, and G. Robertson The fluorimetric assay of triglyceride by a semiautomated method Anal. Biochem. 25 1968 246 251
30. J. Seidel, E. Hagele, J. Ziagenhorn, and A. Wahlefield Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency Clin. Chem. 29 1983 1075 1080
31. G. Bucolo, and H. David Quantitative determination of serum triglycerides by the use of enzymes Clin. Chem. 19 1973 476 482
32. G.R. Warnick, and J.J. Albers A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol J. Lipid Res. 19 1978 65 76
33. M. Laakso How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137 1993 959 965
34. D. Collett Modelling survival data in medical research 1994 Chapman & Hall London
35. J. Stevens Applied multivariate statistics for the social sciences 1986 Lawrence Erlbaum Associates Hillsdale, NJ 337 350
36. I.F. Godsland, J.R. Rosankiewicz, A.J. Proudler, and D.G. Johnston Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men J. Clin. Endocrinol. Metab. 86 2001 719 723
37. J. Danesh, R. Collins, R. Peto, and G. Lowe Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analysis of prospective studies of coronary heart disease Eur Heart J. 21 2000 515 520
38. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, and P. Appleby Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis Br. Med. J. 321 2000 208 213
39. J.L. Witztum The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795
40. S.J. Pocock, A.G. Shaper, D.G. Cook, A.N. Phillips, and M. Walker Social class differences in ischaemic heart disease in British men Lancet ii 1987 197 201
41. P.M. McKeigue, J.E. Ferrie, T. Pierpoint, and M.G. Marmot Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinaemia Circulation 87 1993 152 161
42. E. Brunner, A. Nicholson, and M.G. Marmot Trends in central obesity and insulin resistance across employment grades: the Whitehall II Study J. Epidemiol. Community. Health 47 1993 404 405
43. T.J. Aitman, I.F. Godsland, B. Farren, D. Crook, J. Wong, and J. Scott Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidaemia Arterioscler. Thromb. Vasc. Biol. 17 1997 748 754
44. J.F. Gautier, M.R. Milner, E. Elam, K. Chen, E. Ravussin, and R.E. Pratley Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion Diabetologia 42 1999 28 34
45. C. Walton, I. Godsland, A. Proudler, C. Felton, and V. Wynn Effect of body mass index and fat distribution on insulin sensitivity, secretion and clearance in nonobese, healthy men J. Clin. Endocrinol. Metab. 75 1992 170 175
46. C. Walton, B. Lees, D. Crook, M. Worthington, I.F. Godsland, and J.C. Stevenson Body fat distribution rather than overall adiposity influences serum lipids and lipoproteins in healthy men independently of age Am. J. Med. 99 1995 459 464